Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cognitive and Behavioral Effects of Eslicarbazepine vs Carbamazepine in Healthy Adults
NCT02912364Phase 4Completed
- Sponsor
- Stanford University
- Start
- Jul 2016
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of eslicarbazepine acetate in epilepsy (2 arms), sponsored by Stanford University. Primary endpoint: Overall Composite Z Score of Neuropsychological Battery at 6 weeks. Started Jul 2016; status: completed.
02
Drugs
eslicarbazepine acetate
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT02912364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02912364.